The Health Management & Policy Governance Lab analyzes politics and policymaking to understand how these factors contribute to our health.
Is Europe…getting it right?
The EU’s response to the COVID-19 pandemic has improved considerably since March. But how much longer term transformation will we see in EU public health and health systems policies, and for what purpose?
Four years on, Brexit negotiations still risk damaging the UK’s NHS
All forms of Brexit are likely to have negative consequences for health in the UK, but some forms are worse than others. Our latest paper looks at the current negotiating positions of the UK and EU and the prospects for a deal by the end of the transition period.
COVID-19 is making civil society more important than ever, but also more fragile.
The European response to COVID-19 relies heavily on civil society organizations. But the pandemic also highlights the sector’s vulnerabilities.
Don’t Balk this Balkan: Why Greece was an outlier in the EU’s COVID-19 Response
The success of Greece in responding to the COVID-19 pandemic should not be a surprise. It came about through leadership, not luck.
Antibody Tests and Regulatory Reforms: Why Delegating Pre-Market Control to Private Companies is a Bad Idea
Europe’s experience with regulating medical devices shows why allowing companies to bring antibody tests to market without regulatory approval could do more harm than good.
What we can learn from COVID-19 transition planning in Europe?
European countries are relaxing their physical distancing measures in some of the same ways as US states, but with more social policy support.